Integrative Group Program for Type 2 Diabetes Mellitus (T2DM)
NCT ID: NCT05888454
Last Updated: 2024-02-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
120 participants
INTERVENTIONAL
2023-07-24
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Couples-based Approach for Increasing Physical Activity Among Adults With Type 2 Diabetes
NCT02579395
A Participatory Approach to Support Glucose Tolerance Tracking in Real-Life of Patients With Type 2 Diabetes
NCT06864546
Randomized Trial of Peer Led Education-Project Dulce
NCT01238289
Together on Diabetes Study: Evaluation of a Pilot Diabetes Prevention and Management Program for American Indian Youth
NCT01910727
Healthcare Intervention Program on Treatment Adherence in People With Newly Diagnosed Type 2 Diabetes Mellitus.
NCT05719675
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Group
Conventional treatment for T2DM + Integrative Group Program
Integrative Group Program
The integrative group program consists of 6 in-person sessions directed by a health coach and occurring every other week, and 6 asynchronous educative sessions during a period of 12 weeks.
Conventional treatment for T2DM
Conventional medical treatment for T2DM
Control Group
Conventional treatment for T2DM
Conventional treatment for T2DM
Conventional medical treatment for T2DM
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Integrative Group Program
The integrative group program consists of 6 in-person sessions directed by a health coach and occurring every other week, and 6 asynchronous educative sessions during a period of 12 weeks.
Conventional treatment for T2DM
Conventional medical treatment for T2DM
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 to 80 years
* Current residence in Nuevo León, México
* Availability to attend in-person sessions
* Provides written informed consent
* Able to read and write
Exclusion Criteria
* T2DM diagnosis more than 5 years ago
* Comorbidities such as active cancer, acquired immunodeficiency (HIV+, AIDS), liver, cardiovascular, renal, pulmonary or thyroid disease.
* History of severe neurologic or psychiatric disease (current or past diagnosis)
* Currently pregnant or intention of pregnancy in the following 3 months
* Males that consume more than 4 alcoholic beverages daily or 14 weekly
* Females that consume more than 3 alcoholic beverages daily or 7 weekly
* Consumption of any illicit drug
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TecSalud
UNKNOWN
Fundación Santos y de la Garza Evia I.B.P
UNKNOWN
TecSalud Investigación Clínica
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tania Zertuche, MD
Role: PRINCIPAL_INVESTIGATOR
Director de Instituto de Bienestar y Prevención
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro Médico Zambrano Hellion, Fundación Santos y de la Garza Evia I.B.P, TecSalud
San Pedro Garza García, Nuevo León, Mexico
Centro de Salud Integral, Fundación Santos y de la Garza Evia I.B.P, TecSalud
Santa Catarina, Nuevo León, Mexico
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Dando pasos juntos
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.